Cold Spray for Pain and Ecchymosis After Anticoagulant Prophylaxis in Orthopedic Surgery
The Effect of Cold Spray Application in Reducing Pain and Ecchymosis in Patients Receiving Low Molecular Weight Heparin Prophylaxis After Orthopedic Surgery
1 other identifier
interventional
101
1 country
1
Brief Summary
Heparin is a widely used anticoagulant for thrombosis prevention, and low molecular weight heparin (LMWH) has become the preferred option due to its higher bioavailability, strong antithrombotic effect, and lower risk of complications. However, subcutaneous LMWH injections-commonly administered in the abdomen, arm, or thigh-often cause local side effects such as pain, ecchymosis, and hematoma. The incidence of ecchymosis after injection ranges between 26-89%, and various factors such as injection site, needle size, injection duration, and techniques can influence these outcomes. Cold application is frequently used to reduce injection-related pain and bruising by inducing vasoconstriction, decreasing nerve conduction, and increasing pain tolerance. In orthopedic surgery patients, limited injection sites due to dressings, casts, or splints may increase the risk of repeated bruising and pain. Although cold compresses have been studied in reducing injection-related complications, no research has evaluated the effect of cold spray prior to LMWH administration in this patient group. Therefore, standardized studies are needed to determine whether cold spray is an effective, practical alternative for reducing pain and ecchymosis following LMWH prophylaxis after orthopedic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 19, 2025
CompletedFirst Posted
Study publicly available on registry
September 29, 2025
CompletedOctober 7, 2025
October 1, 2025
2 days
September 19, 2025
October 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain Intensity
Pain intensity at the injection site will be measured using the Visual Analog Scale (VAS). 10-cm VAS scale (0 = no pain, 10 = worst possible pain).
Immediately after each LMWH injection.
Ecchymosis Area
The size of ecchymosis at the injection site will be measured using the Opsite-Flexigrid transparent film. Area calculated in cm² by tracing the ecchymosis on the grid.
48 and 72 hours after injection.
Study Arms (2)
Cold Spray Application
EXPERIMENTALIn patients who receive standard and routine subcutaneous low molecular weight heparin (LMWH) prophylaxis after orthopedic surgery, cold spray is applied to the injection site before this injection.
Standart (Routine) Care
NO INTERVENTIONThis injection is administered without cold application to patients receiving standard and routine subcutaneous low molecular weight heparin (LMWH) prophylaxis after orthopedic surgery.
Interventions
A cold spray is applied to the skin at the planned injection site immediately before LMWH administration to reduce pain and ecchymosis.
Eligibility Criteria
You may qualify if:
- Patients who are:
- years of age or older
- Receiving 1 x 0.4 ml anticoagulant therapy
- Are on the first day of LMWH therapy
- Have no infection, scar tissue, lipodystrophy, or incision at the injection site
- Have not received any other parenteral therapy at the injection site
- Are not allergic to cold or heparin
- Volunteer to participate in the study
You may not qualify if:
- Patients were excluded from the study if they were: • Pregnant, • Had any acute or chronic coagulation disorder or hematological disease,
- Had a subcutaneous injection into the same area 24 hours prior,
- Wanted to withdraw from the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kocaeli University
Köseköy, Kocaeli, 41100, Turkey (Türkiye)
Related Publications (16)
Ekanayake C, Gamage JCPH, Mendis P, Weerasinghe P. Revolution in orthopedic immobilization materials: A comprehensive review. Heliyon. 2023 Feb 16;9(3):e13640. doi: 10.1016/j.heliyon.2023.e13640. eCollection 2023 Mar.
PMID: 36915506RESULTSendir M, Buyukyilmaz F, Celik Z, Taskopru I. Comparison of 3 methods to prevent pain and bruising after subcutaneous heparin administration. Clin Nurse Spec. 2015 May-Jun;29(3):174-80. doi: 10.1097/NUR.0000000000000129.
PMID: 25856035RESULTErek Kazan, E. (2021). Hot and cold applications. In M. Kara Kaşıkçı & E. Akın (Eds.), Fundamentals of nursing: Concepts, principles, practices (1st ed., pp. 492-515). Istanbul Medical Bookstores.
RESULTLafcı, D. (2021). Hot and cold applications. In N. Sabuncu, S. Erkal İlhan, & Z. Koç (Eds.), Fundamentals of nursing care: Concepts, principles, practices (pp. 801-823). Alter Publishing.
RESULTÇalışkan, N. (2021). Hot and cold applications. In T. Atabek Aşti & A. Karadağ (Eds.), Fundamentals of nursing: From knowledge to practice - Concepts, principles, skills (2nd ed., pp. 567-586). Akademi Publishing.
RESULTAltaie, A. H., AbdulRazzaq, H. A., & Abd Al-hadi, A. (2013). Dose effect and risk factors on the severity of enoxaparin bruising side effect. International Journal of Clinical Pharmacy, 35(5), 950.
RESULTPalese A, Aidone E, Dante A, Pea F. Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover study. J Cardiovasc Nurs. 2013 Sep-Oct;28(5):473-82. doi: 10.1097/JCN.0b013e3182578b87.
PMID: 22760174RESULTBayram SB, Gulnar E, Caliskan N, Kosucu P, Bektas O, Bayram A, Aksoy F. The Effect of Two Types of Subcutaneous Heparin Injections on Pain, Ecchymosis, Hematoma and Drug Absorption: A Quasi-Experimental Study. J Eval Clin Pract. 2025 Feb;31(1):e14266. doi: 10.1111/jep.14266.
PMID: 39660578RESULTAmaniyan S, Varaei S, Vaismoradi M, Haghani H, Sieloff C. Effect of local cold and hot pack on the bruising of enoxaparin sodium injection site: a randomized controlled trial. Contemp Nurse. 2016 Feb;52(1):30-41. doi: 10.1080/10376178.2016.1190289. Epub 2016 Jun 5.
PMID: 27207493RESULTKaradag S, Aydinli A, Yilmaz C, Tutar N. Effect of cold application and compression on pain and bruising in subcutaneous heparin injection. J Vasc Nurs. 2023 Mar;41(1):22-26. doi: 10.1016/j.jvn.2023.01.002. Epub 2023 Jan 17.
PMID: 36898801RESULTTosun, H. (2019). Medication management: Oral and local drug administration. In T. Atabek Aşti & A. Karadağ (Eds.), Fundamentals of nursing: From knowledge to practice - Concepts, principles, skills. Akademi Publishing.
RESULTTaylor, C., Lynn, P., & Bartlett, J. (2018). Fundamentals of nursing: The art and science of person-centered care (pp. 59-380). Wolters Kluwer.
RESULTDuruk, N. (2023). Nursing functions and roles. In M. Kara Kaşıkçı & E. Akın (Eds.), Fundamentals of nursing: Concepts, principles, practices (pp. 11-17). Istanbul Medical Bookstores.
RESULTFlevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF. Thromboembolism prophylaxis in orthopaedics: an update. EFORT Open Rev. 2018 Apr 27;3(4):136-148. doi: 10.1302/2058-5241.3.170018. eCollection 2018 Apr.
PMID: 29780621RESULTHallan SS, Kaur V, Jain V, Mishra N. Development and characterization of polymer lipid hybrid nanoparticles for oral delivery of LMWH. Artif Cells Nanomed Biotechnol. 2017 Dec;45(8):1631-1639. doi: 10.1080/21691401.2016.1276920. Epub 2017 Jan 10.
PMID: 28071140RESULTWang H, Guan J, Zhang X, Wang X, Ji T, Hou D, Wang G, Sun J. Effect of Cold Application on Pain and Bruising in Patients With Subcutaneous Injection of Low-Molecular-Weight Heparin: A Meta-Analysis. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620905349. doi: 10.1177/1076029620905349.
PMID: 32372652RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
YASEMİN ÖZHANLI, Assist.Prof
Kocaeli University
- STUDY CHAIR
HATİCE MERVE ALPTEKİN, Research Assistant
Kocaeli University
- STUDY CHAIR
ALİ OSMAN ALTUNTAŞ, Student
Kocaeli University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The study employed a single-blind design. To prevent bias in the analysis of the research data, blinding was also applied to the outcomes assessor and statistician. The care provider and researcher in the study were composed of different individuals. When coding the research data, the study groups were coded as A and B, preventing the statistician from knowing which letter represented which group.
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
September 19, 2025
First Posted
September 29, 2025
Study Start
February 1, 2024
Primary Completion
February 3, 2024
Study Completion
February 1, 2025
Last Updated
October 7, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share